Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 6/20 | 0.45 |
| ▸ | HTR1B | P28222 | 6/20 | 0.45 |
| ▸ | DRD2 | P14416 | 3/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10340261 | 0.89 | MTNR1A (0.49) | HTR1DHTR1BDRD2MTNR1AMTNR1B | |
| SCHEMBL9534389 | 0.86 | HTR1D (0.46) | HTR1DHTR1BDRD2MTNR1AMTNR1B | |
| SCHEMBL9776435 | 0.81 | HTR1D (0.44) | HTR1DHTR1BDRD2MTNR1AMTNR1B | |
| SCHEMBL9534053 | 0.79 | HTR1A (0.54) | HTR1DHTR1BMTNR1AMTNR1BHTR1A | |
| SCHEMBL6890172 | 0.77 | HTR1A (0.65) | HTR1DHTR1BMTNR1AMTNR1BHTR1A | |
| SCHEMBL11019525 | 0.77 | MTNR1A (0.54) | HTR1DHTR1BDRD2MTNR1AMTNR1B | |
| Hydrochloric Acid SCHEMBL7716614 | 0.76 | HTR1A (0.64) | HTR1DHTR1BMTNR1AMTNR1BHTR1A | |
| SCHEMBL9536375 | 0.76 | DRD2 (0.42) | HTR1DHTR1BDRD2MTNR1AMTNR1B | |
| SCHEMBL11021107 | 0.75 | HTR1A (0.56) | HTR1DHTR1BMTNR1AMTNR1BHTR1A | |
| SCHEMBL10340387 | 0.74 | HTR1A (0.60) | HTR1DHTR1BMTNR1AMTNR1BHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0332968-B1 | 1,3,4,5-Tetrahydrobenz[c,d]indoles | BAYER AG (DE) | 1993-06-02 | — | — | EP | disclosed |
| US-5021438-A | Having affinity for 5-hydroxytryptamine receptors; treating central nervous system and cardiovascular disorders | BAYER AKTIENGESELLSCHAFT (DE) | 1991-06-04 | — | — | US | disclosed |
| EP-0332968-A1 | 1,3,4,5-Tetrahydrobenz[c,d]indoles | BAYER AG (DE) | 1989-09-20 | — | — | EP | disclosed |